IndraLab
Statements
sparser
"SOX2, a transcription factor, has been found to be one of the promoters for LSCC tumorigenesis and drug resistance. xref And in this study, we found that USP34 could interact with SOX2, and prevent SOX2 from degradation through ubiquitin‐proteasome pathway, which further explained one of the reasons why SOX2 was highly expressed in LSCC."